Mechanisms and frequency of resistance to moxifloxacin in comparison with ciprofloxacin in Staphylococcus aureus

被引:5
作者
Ince, D
Aras, R
Hooper, DC
机构
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Infect Dis, Boston, MA 02114 USA
[2] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Med Serv, Boston, MA 02114 USA
关键词
D O I
10.2165/00003495-199958002-00032
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:132 / 133
页数:2
相关论文
共 6 条
[1]   CLONING AND PRIMARY STRUCTURE OF STAPHYLOCOCCUS-AUREUS DNA TOPOISOMERASE-IV - A PRIMARY TARGET OF FLUOROQUINOLONES [J].
FERRERO, L ;
CAMERON, B ;
MANSE, B ;
LAGNEAUX, D ;
CROUZET, J ;
FAMECHON, A ;
BLANCHE, F .
MOLECULAR MICROBIOLOGY, 1994, 13 (04) :641-653
[2]   Mutations in topoisomerase IV and DNA gyrase of Staphylococcus aureus:: Novel pleiotropic effects an quinolone and coumarin activity [J].
Fournier, B ;
Hooper, DC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (01) :121-128
[3]   Quinolone resistance mutations in topoisomerase IV: Relationship to the flqA locus and genetic evidence that topoisomerase IV is the primary target and DNA gyrase is the secondary target of fluoroquinolones in Staphylococcus aureus [J].
Ng, EY ;
Trucksis, M ;
Hooper, DC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (08) :1881-1888
[4]   QUINOLONE RESISTANCE MEDIATED BY NORA - PHYSIOLOGICAL CHARACTERIZATION AND RELATIONSHIP TO FLQB, A QUINOLONE RESISTANCE LOCUS ON THE STAPHYLOCOCCUS-AUREUS CHROMOSOME [J].
NG, EYW ;
TRUCKSIS, M ;
HOOPER, DC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (06) :1345-1355
[5]   In vitro activity of BAY 12-8039, a new fluoroquinolone [J].
Woodcock, JM ;
Andrews, JM ;
Boswell, FJ ;
Brenwald, NP ;
Wise, R .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (01) :101-106
[6]   Killing of Staphylococcus aureus by C-8-methoxy fluoroquinolones [J].
Zhao, XL ;
Wang, JY ;
Xu, C ;
Dong, YZ ;
Zhou, JF ;
Domagala, J ;
Drlica, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (04) :956-958